Please use this identifier to cite or link to this item:
http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/12500
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Todoriko, L.D. | - |
dc.contributor.author | Yeremenchuk, I.V. | - |
dc.contributor.author | Shapovalov, V.P. | - |
dc.contributor.author | Ilchyshyn, T.I. | - |
dc.date.accessioned | 2017-06-09T11:55:37Z | - |
dc.date.available | 2017-06-09T11:55:37Z | - |
dc.date.issued | 2014 | - |
dc.identifier.other | УДК 616.24-002.5-097-07-085.28 | - |
dc.identifier.uri | http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/12500 | - |
dc.description.abstract | As of October 2012 84 countries had re¬ported at least 1 case of extensively drug resistant tuberculosis (EDR TB). In November 2012, the WHO epidemiological surveillance stated: all new TB cases in the world are 3,7 % of multi-drug resistant tuberculosis (MDR TB); 60,0 % of MDR TB among the new cases of TB are documented in Brazil, China, India, and South Africa. | ru_RU |
dc.language.iso | en | ru_RU |
dc.publisher | Буковинський медичний вісник | ru_RU |
dc.subject | tuberculosis | ru_RU |
dc.subject | multi-drug resistant tuberculosis | ru_RU |
dc.subject | fluoroquinolones | ru_RU |
dc.subject | malabsorption syndrome | ru_RU |
dc.subject | туберкулез | ru_RU |
dc.subject | мультирезистентный туберкулез | ru_RU |
dc.subject | фторхинолоны | ru_RU |
dc.subject | синдром мальабсорбции | ru_RU |
dc.subject | туберкульоз | ru_RU |
dc.subject | мультирезистентний туберкульоз | ru_RU |
dc.subject | фторхінолони | ru_RU |
dc.subject | синдром мальабсорбції | ru_RU |
dc.title | Malabsorption syndrome as a manifestation of systemic effects in advanced forms of pulmonary tuberculosis | ru_RU |
dc.type | Article | ru_RU |
Appears in Collections: | Статті. Кафедра фтизіатрії та пульмонології |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.